Assessment of degree of health of the stomach by concomitant measurement of serum pepsinogen and serum Helicobacter pylori antibodies

International Journal of Biological Markers

Volumn 25, Issue 4, 2010, Pages 207-212

  Inoue, Kazuhiko ^a   Fujisawa, Tomoo ^a   Haruma, Ken ^b  

^a MATSUE RED CROSS HOSPITAL   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Gastric cancer screening; Helicobacter pylori; Latex immunoassay; Pepsinogen

Indexed keywords

BACTERIUM ANTIBODY; PEPSINOGEN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME BLOOD LEVEL; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; IMMUNOASSAY; LATEX IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; REFLUX ESOPHAGITIS; STOMACH ADENOMA; STOMACH CANCER; STOMACH POLYP;

ADENOMA; ADULT; AGED; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; EARLY DETECTION OF CANCER; HELICOBACTER PYLORI; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; PEPSINOGEN A; RISK FACTORS; STOMACH; STOMACH NEOPLASMS; YOUNG ADULT;

HELICOBACTER PYLORI;

EID: 78650818487     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2010.6087     Document Type: Article

References (30)

1. Tubono Y, Hisamichi S. Screening for gastric cancer in Japan. Gastric Cancer 2000; 3: 9-18.
2. Oshima A, Hirata N, Ubutaka T, Fujimoto I. Evaluation of the mass screening program for stomach cancer with a case control study design. Int J Cancer 1986; 38: 829-33.
3. Fukao A, Tsubono Y, Tuji I, et al. The evaluation of screening for gastric cancer in Miyagi Prefecture, Japan: a population-based case-control study. Int J Cancer 1995; 60: 45-8.
4. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995; 19 (suppl 1): S37-43.
5. Samloff IM, Secrist DM, Passoro EJ. A study of the relationship between serum group I pepsinogen levels and gastric acid secretion. Gastroenterology 1975; 69: 1196-2000.
6. Samloff IM. Pepsinogens I and II: Purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology 1982; 82: 26-33.
7. Samloff IM, Varis K, Ihamaki T, et al. Relationship among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982; 83: 204-9.
8. Miki K, Ichinose M, Shimizu A, et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987; 22: 133-41.
9. Miki K, Ichinose M, Ishikawa K, et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res 1993; 84: 1086-90.
10. Yoshihara M, Sumii K, Haruma K, et al. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 1998; 93: 1090-6.
11. Yoshihara M, Sumii K, Haruma K, et al. Gastric mass survey with measurement of serum pepsinogen levels in a local area. Situation and practical method of the pepsinogen method in a local area. J Gastroenterol Mass Survey 1996; 34: 325-30 (in Japanese with English abstract).
12. Inoue K, Tani M, Yoshihara M. Evaluation of combined uses of serum pepsinogen method and Helicobacter pylori antibody value for gastric cancer: in comparison with endoscopic findings on the same day. J Gastroenterol Mass Survey 2005; 43: 332-9 (in Japanese with English abstract).
13. Inoue K, Tani M, Yoshihara M. Gastric cancer and gastric adenoma diagnosed in follow-up examination over 1 year after testing with the pepsinogen method and measurement of the Helicobacter pylori antibody value. J Gastroenterol Mass Survey 2005; 43: 442-8 (in Japanese with English abstract).
14. Japanese Research Society for Gastric Cancer. The general rules for gastric cancer. Jpn J Surg 1973; 3: 61-71.
15. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-80.
16. Hamashima C, Shibuya D, Yamazaki H, et al. The Japanese guideline for gastric cancer screening. Jpn J Clin Oncol 2008; 38: 259-67.
17. Yoshihara M, Hiyama T, Yoshida S, et al. Reduction in gastric cancer by screening based on serum pepsinogen concentration: A case-control study. Scand J Gastroenterol 2007; 42: 760-4.
18. Watanabe T, Tada M, Nagai H, et al. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998; 115: 642-8.
19. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
20. Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004; 109: 138-43.
21. Sipponen P, Ranta P, Helske T, et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: observational case-control study. Scand J Gastroenterol 2002; 37: 785-91.
22. Vaananen H, Vauhkonen M, Helske T, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicenter study. Eur J Gastroenterol Hepatol 2003; 15: 885-91.
23. Pasechnikov VD, Chukov SZ, Kotelevets SM, et al. Possibility of non-invasive diagnosis of gastric mucosal precancerous changes. World J Gastroenterol 2004; 10: 3146-50.
24. Biohit Corporation. GastroPanel. http://www.gastropanel.net/index.php.
25. Iijima K, Abe Y, Kikuchi R, et al. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol 2009; 15: 853-9.
26. Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 639-42.
27. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372: 392-7.
28. Kamada T, Hata J, Sugiu H, et al. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan. Aliment Pharmacol Ther 2005; 21: 1121-6.
29. Miki K, Sasajima M, Hoshina R, et al. Basic evaluation of serum pepsinogen measurement using latex agglutination turbidimetric immunoassay kit, LZ test 'Eiken'. Jpn J Med Pharm Sci 2003; 49: 519-24 (in Japanese).
30. Miki K, Fujishiro M. Cautious comparison between East and West is necessary in terms of the serum pepsinogen test. Dig Endosc 2009; 21: 134-5.